Two Sigma Advisers’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,800
| Closed | -$102K | – | 2366 |
|
|
2025
Q1 | $102K | Sell |
12,800
-93,800
| -88% | -$744K | ﹤0.01% | 2240 |
|
|
2024
Q4 | $1.35M | Sell |
106,600
-8,500
| -7% | -$108K | ﹤0.01% | 1319 |
|
|
2024
Q3 | $1.6M | Buy |
115,100
+30,800
| +37% | +$429K | ﹤0.01% | 1189 |
|
|
2024
Q2 | $1.16M | Buy |
+84,300
| New | +$1.16M | ﹤0.01% | 1475 |
|
|
2023
Q3 | – | Sell |
-16,400
| Closed | -$196K | – | 2430 |
|
|
2023
Q2 | $196K | Buy |
+16,400
| New | +$196K | ﹤0.01% | 2105 |
|
|
2022
Q2 | – | Sell |
-19,900
| Closed | -$197K | – | 2703 |
|
|
2022
Q1 | $197K | Buy |
+19,900
| New | +$197K | ﹤0.01% | 2386 |
|